19 June 2013
Keywords: powdermed, initiates, ph, trial, dna, flu, vacc
Article | 09 October 2006
UK immunotherapeutics specialist PowderMed says it will begin testing a DNA-based annual influenza vaccine in a US Phase I trial ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.